Apex Healthcare Stock

Equities

AHEALTH

MYL7090OO003

Pharmaceuticals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
2.99 MYR -0.33% Intraday chart for Apex Healthcare -1.64% +20.08%
Sales 2024 * 999M 209M Sales 2025 * 1.06B 222M Capitalization 2.15B 449M
Net income 2024 * 95M 19.87M Net income 2025 * 105M 21.96M EV / Sales 2024 * 1.94 x
Net cash position 2024 * 206M 43.07M Net cash position 2025 * 221M 46.16M EV / Sales 2025 * 1.82 x
P/E ratio 2024 *
22.6 x
P/E ratio 2025 *
20.5 x
Employees -
Yield 2024 *
1.92%
Yield 2025 *
2.3%
Free-Float 49.12%
More Fundamentals * Assessed data
Dynamic Chart
Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023 CI
Apex Healthcare Boosts Dividend Despite Profit Decline in Q4 MT
Apex Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apex Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Apex Healthcare Berhad Announces the Final Single-Tier Dividend for the Financial Year Ended December 31, 2023, Payment Date 29 May 2024 CI
Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023 CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024 CI
Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024 CI
Apex Healthcare Profit Declines in Q3 MT
Apex Healthcare Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Apex Healthcare's Profit Shoots Up in Q2 MT
Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023 CI
Apex Healthcare Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2023, Payable on 19 September 2023 CI
Apex Healthcare's Profit Climbs in Q1 MT
More news
1 day-0.33%
1 week-1.64%
Current month+1.36%
3 months+15.00%
6 months+19.60%
Current year+20.08%
More quotes
1 week
2.90
Extreme 2.9
3.06
1 month
2.90
Extreme 2.9
3.07
Current year
2.49
Extreme 2.49
3.16
1 year
2.34
Extreme 2.34
3.16
3 years
1.59
Extreme 1.5867
3.16
5 years
1.18
Extreme 1.18
3.16
10 years
0.51
Extreme 0.5133
3.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 00-02-14
Director of Finance/CFO 50 01-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 73 00-02-22
Director/Board Member 72 00-02-17
Chief Executive Officer 62 00-02-14
More insiders
Date Price Change Volume
24-04-19 2.99 -0.33% 104,300
24-04-18 3 +0.67% 82,800
24-04-17 2.98 +1.36% 171,300
24-04-16 2.94 -1.67% 205,900
24-04-15 2.99 -1.64% 591,800

End-of-day quote BURSA MALAYSIA, April 18, 2024

More quotes
Apex Healthcare Berhad is a Malaysia-based healthcare company. The Company is focused on the development, manufacturing, wholesaling, marketing and distribution of pharmaceuticals, consumer healthcare products, and medical devices. It operates through three segments: Manufacturing, Distribution and Corporate. It is engaged in the manufacturing of pharmaceutical products. It is involved in the distribution of pharmaceutical and healthcare products. The Corporate segment comprises investments, properties and others. It is also engaged in the contract manufacturing of orthopedic devices. Its brands include XEPATM, AVO, AGNESIA, AEVA and HENNSON, and products bearing these brands are sold in approximately 16 territories worldwide. The Company's distribution channels reach hospitals, clinics, independent and chain pharmacies, supermarkets and health stores, enabling products to reach customers, namely doctors, pharmacists, nutritionists, retailers, and ultimately the patients or consumers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
2.99 MYR
Average target price
2.644 MYR
Spread / Average Target
-11.57%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AHEALTH Stock